Analyst Price Targets — CRL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 20, 2026 12:29 pm | — | Mizuho Securities | $175.00 | $164.24 | TheFly | Charles River price target lowered to $175 from $215 at Mizuho |
| February 19, 2026 1:56 pm | Eric Coldwell | Robert W. Baird | $193.00 | $158.18 | TheFly | Charles River price target lowered to $193 from $231 at Baird |
| February 19, 2026 11:31 am | Luke Sergott | Barclays | $200.00 | $158.00 | TheFly | Charles River price target lowered to $200 from $215 at Barclays |
| January 13, 2026 1:33 pm | — | Robert W. Baird | $231.00 | $221.69 | TheFly | Charles River price target raised to $231 from $224 at Baird |
| January 13, 2026 12:54 pm | — | Evercore ISI | $260.00 | $225.11 | TheFly | Charles River price target raised to $260 from $250 at Evercore ISI |
| January 9, 2026 1:11 pm | Eric Coldwell | Robert W. Baird | $224.00 | $219.49 | TheFly | Charles River price target raised to $224 from $199 at Baird |
| January 9, 2026 12:08 pm | Ann Hynes | Mizuho Securities | $215.00 | $215.51 | TheFly | Charles River price target raised to $215 from $200 at Mizuho |
| December 18, 2025 12:06 pm | — | Mizuho Securities | $200.00 | $195.98 | TheFly | Charles River price target raised to $200 from $174 at Mizuho |
| December 15, 2025 10:54 am | — | Barclays | $215.00 | $192.97 | TheFly | Charles River price target raised to $215 from $210 at Barclays |
| December 1, 2025 9:16 pm | Kallum Titchmarsh | Morgan Stanley | $185.00 | $176.09 | StreetInsider | Morgan Stanley Assumes Charles River Labs (CRL) at Equalweight |
Latest News for CRL
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at TD Cowen and Barclays Conferences.
Contract drug developer Charles River Laboratories raised its 2026 profit forecast on Wednesday, after it announced the sales of some underperforming assets to peer IQVIA and private equity firm GI Partners.
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Provides Update on Planned Divestitures.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CRL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.